| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.937 | 0.004 | 0.942 | Analgesic | 0.942 0.004 DBMET03692 0.883 0.005 DBMET03695 0.814 0.005 DBMET03696 0.932 0.004 DBMET00934 0.81 0.005 DBMET03693 | DBMET03692 | |
| 0.71 | 0.008 | 0.712 | Aldehyde oxidase inhibitor | 0.712 0.007 DBMET03692 0.513 0.031 DBMET00934 | DBMET03692 | |
| 0.632 | 0.003 | 0.645 | Analgesic, opioid | 0.645 0.003 DBMET03692 0.403 0.005 DBMET03695 0.316 0.005 DBMET03696 0.557 0.004 DBMET00934 0.342 0.005 DBMET03693 | DBMET03692 | |
| 0.61 | 0.012 | 0.732 | Spasmolytic | 0.611 0.012 DBMET03692 0.491 0.024 DBMET03695 0.712 0.005 DBMET03696 0.456 0.03 DBMET00934 0.732 0.005 DBMET03693 | DBMET03693 | |
| 0.553 | 0.003 | 0.574 | Opioid mu receptor agonist | 0.574 0.003 DBMET03692 0.211 0.005 DBMET03695 0.177 0.005 DBMET03696 0.436 0.003 DBMET00934 0.204 0.005 DBMET03693 | DBMET03692 | |
| 0.524 | 0.013 | 0.791 | Vasodilator, coronary | 0.527 0.012 DBMET03692 0.495 0.016 DBMET03695 0.791 0.004 DBMET03696 0.424 0.029 DBMET00934 0.787 0.004 DBMET03693 | DBMET03696 | |
| 0.502 | 0.008 | 0.502 | Anesthetic general | 0.461 0.01 DBMET03692 0.484 0.009 DBMET03696 0.414 0.015 DBMET00934 0.438 0.012 DBMET03693 | ||
| 0.474 | 0.004 | 0.5 | Opioid agonist | 0.5 0.004 DBMET03692 0.127 0.009 DBMET03695 0.12 0.01 DBMET03696 0.377 0.004 DBMET00934 0.14 0.008 DBMET03693 | DBMET03692 | |
| 0.502 | 0.032 | 0.707 | Cholesterol antagonist | 0.435 0.043 DBMET03692 0.308 0.086 DBMET03695 0.707 0.008 DBMET03696 0.422 0.045 DBMET00934 0.683 0.009 DBMET03693 | DBMET03696 | |
| 0.426 | 0.004 | 0.512 | Adrenaline uptake inhibitor | 0.439 0.004 DBMET03692 0.259 0.005 DBMET03695 0.164 0.008 DBMET03696 0.512 0.003 DBMET00934 0.149 0.009 DBMET03693 | DBMET00934 | |
| 0.456 | 0.035 | 0.68 | 5 Hydroxytryptamine release stimulant | 0.397 0.046 DBMET03692 0.251 0.088 DBMET03696 0.68 0.008 DBMET00934 0.227 0.101 DBMET03693 | DBMET00934 | |
| 0.442 | 0.054 | 0.555 | Histamine release inhibitor | 0.445 0.052 DBMET03692 0.536 0.019 DBMET03696 0.388 0.082 DBMET00934 0.555 0.015 DBMET03693 | DBMET03693 | |
| 0.39 | 0.009 | 0.402 | Tyrosine 3 hydroxylase inhibitor | 0.36 0.014 DBMET03692 0.199 0.137 DBMET03695 0.402 0.008 DBMET00934 | DBMET00934 | |
| 0.367 | 0.008 | 0.367 | Anesthetic local | 0.356 0.009 DBMET03692 0.124 0.064 DBMET03695 0.304 0.012 DBMET00934 | ||
| 0.335 | 0.003 | 0.341 | Prolactin inhibitor | 0.341 0.003 DBMET03692 0.107 0.049 DBMET03695 0.267 0.004 DBMET00934 | DBMET03692 | |
| 0.36 | 0.034 | 0.395 | Sodium/bile acid cotransporter inhibitor | 0.354 0.037 DBMET03692 0.395 0.018 DBMET03695 0.307 0.073 DBMET03696 0.365 0.031 DBMET00934 0.311 0.07 DBMET03693 | DBMET03695 | |
| 0.301 | 0.001 | 0.301 | Estrogen-related receptor beta agonist | 0.246 0.002 DBMET03692 0.102 0.022 DBMET03695 0.099 0.026 DBMET03696 0.209 0.002 DBMET00934 0.097 0.029 DBMET03693 | ||
| 0.4 | 0.111 | 0.436 | Caspase 9 stimulant | 0.436 0.091 DBMET03692 0.376 0.126 DBMET03696 0.367 0.132 DBMET00934 0.436 0.09 DBMET03693 | DBMET03693 | |
| 0.288 | 0.009 | 0.288 | Nav1.1 sodium channel blocker | 0.277 0.01 DBMET03692 0.121 0.048 DBMET03695 0.255 0.012 DBMET00934 | ||
| 0.283 | 0.02 | 0.367 | Phospholipase C inhibitor | 0.239 0.027 DBMET03692 0.367 0.013 DBMET03695 0.217 0.035 DBMET03696 0.208 0.039 DBMET00934 0.212 0.037 DBMET03693 | DBMET03695 | |
| 0.297 | 0.043 | 0.32 | Psychostimulant | 0.304 0.042 DBMET03692 0.307 0.041 DBMET03696 0.32 0.038 DBMET00934 0.312 0.04 DBMET03693 | DBMET00934 | |
| 0.272 | 0.018 | 0.272 | Nav1.2 sodium channel blocker | 0.22 0.028 DBMET03692 0.116 0.088 DBMET03695 0.249 0.022 DBMET00934 | ||
| 0.334 | 0.082 | 0.716 | Transcription factor NF kappa B inhibitor | 0.358 0.074 DBMET03692 0.667 0.024 DBMET03696 0.367 0.072 DBMET00934 0.716 0.019 DBMET03693 | DBMET03693 | |
| 0.271 | 0.022 | 0.496 | Protein kinase stimulant | 0.297 0.017 DBMET03692 0.452 0.005 DBMET03696 0.324 0.014 DBMET00934 0.496 0.004 DBMET03693 | DBMET03693 | |
| 0.325 | 0.085 | 0.334 | Vasodilator, peripheral | 0.334 0.081 DBMET03692 0.302 0.096 DBMET03696 0.236 0.138 DBMET00934 0.288 0.103 DBMET03693 | DBMET03692 | |
| 0.274 | 0.042 | 0.324 | Peroxidase inhibitor | 0.324 0.033 DBMET03692 0.286 0.04 DBMET03695 0.273 0.043 DBMET00934 | DBMET03692 | |
| 0.327 | 0.099 | 0.387 | GABA C receptor rho-3 antagonist | 0.387 0.067 DBMET03692 0.346 0.088 DBMET00934 | DBMET03692 | |
| 0.327 | 0.099 | 0.508 | Immunosuppressant | 0.342 0.091 DBMET03692 0.506 0.031 DBMET03696 0.333 0.096 DBMET00934 0.508 0.031 DBMET03693 | DBMET03693 | |
| 0.28 | 0.058 | 0.416 | Superoxide dismutase inhibitor | 0.288 0.055 DBMET03692 0.416 0.024 DBMET03695 0.286 0.056 DBMET00934 | DBMET03695 | |
| 0.271 | 0.052 | 0.308 | Amyloid beta aggregation inhibitor | 0.308 0.044 DBMET03692 0.182 0.088 DBMET03696 0.152 0.107 DBMET00934 0.233 0.063 DBMET03693 | DBMET03692 | |
| 0.275 | 0.06 | 0.28 | 5 Hydroxytryptamine uptake stimulant | 0.241 0.09 DBMET03692 0.28 0.057 DBMET00934 | DBMET00934 | |
| 0.218 | 0.011 | 0.218 | Opioid antagonist | 0.218 0.011 DBMET03692 0.093 0.054 DBMET03696 0.206 0.013 DBMET00934 0.109 0.042 DBMET03693 | ||
| 0.278 | 0.074 | 0.297 | Insulysin inhibitor | 0.267 0.081 DBMET03692 0.26 0.088 DBMET03695 0.297 0.06 DBMET00934 | DBMET00934 | |
| 0.239 | 0.045 | 0.266 | Neurotrophic factor enhancer | 0.239 0.045 DBMET03692 0.245 0.041 DBMET03696 0.26 0.033 DBMET00934 0.266 0.03 DBMET03693 | DBMET03693 | |
| 0.249 | 0.058 | 0.249 | Neuropeptide Y2 antagonist | 0.221 0.088 DBMET03692 0.207 0.107 DBMET00934 | ||
| 0.217 | 0.026 | 0.358 | ATPase inhibitor | 0.211 0.029 DBMET03692 0.358 0.004 DBMET03696 0.262 0.011 DBMET00934 0.353 0.004 DBMET03693 | DBMET03696 | |
| 0.197 | 0.013 | 0.296 | Vanilloid 1 agonist | 0.188 0.015 DBMET03692 0.18 0.018 DBMET03696 0.296 0.004 DBMET00934 0.176 0.02 DBMET03693 | DBMET00934 | |
| 0.234 | 0.05 | 0.257 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.257 0.039 DBMET03692 0.168 0.111 DBMET03696 0.161 0.125 DBMET00934 0.195 0.076 DBMET03693 | DBMET03692 | |
| 0.191 | 0.01 | 0.191 | Opioid mu receptor antagonist | 0.189 0.01 DBMET03692 0.069 0.046 DBMET03696 0.177 0.012 DBMET00934 0.087 0.037 DBMET03693 | ||
| 0.188 | 0.012 | 0.188 | Sphingomyelinase inhibitor | 0.18 0.014 DBMET03692 0.176 0.015 DBMET03696 0.148 0.025 DBMET00934 0.138 0.03 DBMET03693 | ||
| 0.185 | 0.014 | 0.185 | TRPA1 agonist | 0.167 0.021 DBMET03692 0.119 0.059 DBMET03696 0.185 0.014 DBMET00934 0.116 0.063 DBMET03693 | ||
| 0.202 | 0.031 | 0.202 | Arachidonic acid antagonist | 0.198 0.034 DBMET03692 0.181 0.053 DBMET03695 0.131 0.111 DBMET03696 0.189 0.044 DBMET00934 | ||
| 0.269 | 0.099 | 0.419 | Interleukin 2 agonist | 0.267 0.101 DBMET03692 0.415 0.023 DBMET03696 0.275 0.093 DBMET00934 0.419 0.022 DBMET03693 | DBMET03693 | |
| 0.185 | 0.022 | 0.223 | Adenylate cyclase stimulant | 0.185 0.022 DBMET03692 0.13 0.102 DBMET03696 0.223 0.006 DBMET00934 0.133 0.095 DBMET03693 | DBMET00934 | |
| 0.245 | 0.086 | 0.313 | Cardiotonic | 0.24 0.089 DBMET03692 0.313 0.051 DBMET03695 0.172 0.148 DBMET03696 0.178 0.141 DBMET00934 | DBMET03695 | |
| 0.232 | 0.081 | 0.372 | Vasodilator | 0.247 0.07 DBMET03692 0.235 0.079 DBMET03695 0.353 0.032 DBMET03696 0.191 0.112 DBMET00934 0.372 0.028 DBMET03693 | DBMET03693 | |
| 0.169 | 0.021 | 0.345 | GABA C receptor antagonist | 0.21 0.011 DBMET03692 0.345 0.004 DBMET03695 0.169 0.021 DBMET00934 | DBMET03695 | |
| 0.165 | 0.019 | 0.175 | Estrogen antagonist | 0.175 0.017 DBMET03692 0.142 0.027 DBMET00934 0.122 0.052 DBMET03693 | DBMET03692 | |
| 0.178 | 0.033 | 0.183 | Cholesterol synthesis inhibitor | 0.183 0.031 DBMET03692 0.13 0.057 DBMET03696 0.138 0.052 DBMET00934 0.141 0.049 DBMET03693 | DBMET03692 | |
| 0.301 | 0.157 | 0.544 | Calcium channel L-type activator | 0.544 0.014 DBMET00934 | DBMET00934 | |
| 0.174 | 0.032 | 0.174 | Nav1.6 sodium channel blocker | 0.167 0.038 DBMET03692 0.122 0.092 DBMET00934 | ||
| 0.186 | 0.044 | 0.202 | Neurotensin receptor agonist | 0.183 0.046 DBMET03692 0.182 0.048 DBMET03695 0.202 0.034 DBMET00934 | DBMET00934 | |
| 0.167 | 0.035 | 0.444 | Cyclooxygenase 3 inhibitor | 0.16 0.04 DBMET03692 0.444 0.004 DBMET03696 0.166 0.036 DBMET00934 0.437 0.004 DBMET03693 | DBMET03696 | |
| 0.228 | 0.096 | 0.584 | Antioxidant | 0.267 0.075 DBMET03692 0.521 0.018 DBMET03696 0.23 0.095 DBMET00934 0.584 0.012 DBMET03693 | DBMET03693 | |
| 0.159 | 0.03 | 0.159 | Nav1.4 sodium channel blocker | 0.155 0.032 DBMET03692 0.156 0.031 DBMET03695 0.148 0.034 DBMET00934 | ||
| 0.167 | 0.038 | 0.167 | Aldehyde dehydrogenase inhibitor | 0.157 0.043 DBMET03692 0.141 0.053 DBMET03696 0.112 0.08 DBMET00934 0.16 0.042 DBMET03693 | ||
| 0.188 | 0.06 | 0.309 | Succinate dehydrogenase inhibitor | 0.184 0.063 DBMET03692 0.309 0.009 DBMET03695 0.181 0.067 DBMET00934 | DBMET03695 | |
| 0.22 | 0.095 | 0.233 | Calpain inhibitor | 0.206 0.108 DBMET03692 0.233 0.082 DBMET03695 0.226 0.088 DBMET00934 | DBMET03695 | |
| 0.213 | 0.091 | 0.367 | Antiamyloidogenic | 0.228 0.082 DBMET03692 0.159 0.135 DBMET03695 0.301 0.051 DBMET03696 0.218 0.088 DBMET00934 0.367 0.035 DBMET03693 | DBMET03693 | |
| 0.192 | 0.07 | 0.203 | P-glycoprotein inhibitor | 0.203 0.062 DBMET03692 0.193 0.068 DBMET03696 0.164 0.097 DBMET00934 0.197 0.066 DBMET03693 | DBMET03692 | |
| 0.162 | 0.041 | 0.162 | Nav1.3 sodium channel blocker | 0.142 0.053 DBMET03692 0.125 0.068 DBMET00934 | ||
| 0.155 | 0.034 | 0.168 | Sphingosine 1-phosphate receptor 2 antagonist | 0.168 0.023 DBMET03692 0.163 0.027 DBMET03695 0.161 0.029 DBMET00934 | DBMET03692 | |
| 0.166 | 0.046 | 0.179 | Neurotrophic factor | 0.179 0.038 DBMET03692 0.144 0.064 DBMET03696 0.132 0.077 DBMET00934 0.15 0.059 DBMET03693 | DBMET03692 | |
| 0.293 | 0.174 | 0.366 | 5 Hydroxytryptamine release inhibitor | 0.291 0.175 DBMET03692 0.359 0.108 DBMET03696 0.298 0.168 DBMET00934 0.366 0.102 DBMET03693 | DBMET03693 | |
| 0.131 | 0.013 | 0.152 | Estrogen agonist | 0.152 0.011 DBMET03692 0.063 0.029 DBMET03695 0.071 0.026 DBMET03696 0.101 0.017 DBMET00934 0.112 0.015 DBMET03693 | DBMET03692 | |
| 0.26 | 0.142 | 0.336 | Calpain 2 inhibitor | 0.232 0.162 DBMET03692 0.326 0.099 DBMET03695 0.336 0.093 DBMET00934 | DBMET00934 | |
| 0.224 | 0.107 | 0.544 | Immunostimulant | 0.249 0.097 DBMET03692 0.515 0.027 DBMET03696 0.192 0.125 DBMET00934 0.544 0.023 DBMET03693 | DBMET03693 | |
| 0.133 | 0.021 | 0.139 | Estrogen receptor beta antagonist | 0.139 0.019 DBMET03692 0.122 0.03 DBMET00934 | DBMET03692 | |
| 0.177 | 0.067 | 0.177 | Antipruritic | 0.166 0.078 DBMET03692 0.17 0.074 DBMET00934 | ||
| 0.158 | 0.047 | 0.158 | Toll-Like receptor 2 antagonist | 0.138 0.061 DBMET03692 0.156 0.049 DBMET00934 | ||
| 0.242 | 0.132 | 0.664 | Antithrombotic | 0.246 0.129 DBMET03692 0.372 0.057 DBMET03695 0.664 0.01 DBMET03696 0.238 0.136 DBMET00934 0.663 0.01 DBMET03693 | DBMET03696 | |
| 0.125 | 0.017 | 0.127 | Estrogen receptor alpha antagonist | 0.127 0.016 DBMET03692 0.086 0.04 DBMET00934 | DBMET03692 | |
| 0.212 | 0.109 | 0.347 | Interleukin agonist | 0.216 0.106 DBMET03692 0.347 0.03 DBMET03696 0.235 0.09 DBMET00934 0.333 0.034 DBMET03693 | DBMET03696 | |
| 0.165 | 0.064 | 0.355 | Melanin inhibitor | 0.172 0.058 DBMET03692 0.279 0.025 DBMET03696 0.16 0.069 DBMET00934 0.355 0.016 DBMET03693 | DBMET03693 | |
| 0.15 | 0.049 | 0.189 | DNA polymerase I inhibitor | 0.174 0.038 DBMET03692 0.168 0.04 DBMET03696 0.126 0.064 DBMET00934 0.189 0.032 DBMET03693 | DBMET03693 | |
| 0.183 | 0.085 | 0.409 | Non-steroidal antiinflammatory agent | 0.166 0.098 DBMET03692 0.409 0.012 DBMET03696 0.141 0.128 DBMET00934 0.38 0.016 DBMET03693 | DBMET03696 | |
| 0.132 | 0.036 | 0.138 | Carbonic anhydrase III inhibitor | 0.138 0.034 DBMET03692 0.136 0.034 DBMET03695 0.094 0.069 DBMET00934 0.094 0.069 DBMET03693 | DBMET03692 | |
| 0.135 | 0.042 | 0.24 | Photosensitizer | 0.159 0.026 DBMET03692 0.228 0.008 DBMET03695 0.198 0.013 DBMET03696 0.24 0.007 DBMET03693 | DBMET03693 | |
| 0.112 | 0.02 | 0.112 | GABA aminotransferase inhibitor | 0.098 0.029 DBMET03692 0.099 0.027 DBMET03696 0.103 0.025 DBMET00934 0.096 0.03 DBMET03693 | ||
| 0.259 | 0.169 | 0.656 | Antibacterial | 0.302 0.134 DBMET03692 0.246 0.181 DBMET03695 0.631 0.015 DBMET03696 0.277 0.153 DBMET00934 0.656 0.012 DBMET03693 | DBMET03693 | |
| 0.214 | 0.128 | 0.313 | Gastrin inhibitor | 0.205 0.141 DBMET03692 0.313 0.025 DBMET03695 0.237 0.096 DBMET00934 | DBMET03695 | |
| 0.189 | 0.103 | 0.359 | Cyclic AMP phosphodiesterase inhibitor | 0.213 0.085 DBMET03692 0.334 0.03 DBMET03696 0.359 0.024 DBMET03693 | DBMET03693 | |
| 0.155 | 0.07 | 0.219 | Acetylcholine M1 receptor antagonist | 0.14 0.084 DBMET03692 0.219 0.035 DBMET03695 | DBMET03695 | |
| 0.103 | 0.019 | 0.103 | CC chemokine 5 receptor agonist | 0.093 0.032 DBMET03692 0.092 0.033 DBMET00934 | ||
| 0.13 | 0.047 | 0.138 | Falcipain 3 inhibitor | 0.138 0.042 DBMET03692 0.087 0.085 DBMET00934 | DBMET03692 | |
| 0.121 | 0.04 | 0.135 | Creatine kinase inhibitor | 0.135 0.031 DBMET03692 0.104 0.056 DBMET00934 | DBMET03692 | |
| 0.128 | 0.047 | 0.194 | Mucolytic | 0.133 0.044 DBMET03692 0.194 0.015 DBMET03695 0.137 0.04 DBMET03696 0.113 0.061 DBMET00934 0.144 0.036 DBMET03693 | DBMET03695 | |
| 0.088 | 0.008 | 0.088 | Squalene epoxidase inhibitor | 0.082 0.009 DBMET03692 0.046 0.044 DBMET03696 0.075 0.012 DBMET00934 | ||
| 0.097 | 0.018 | 0.122 | GABA B receptor agonist | 0.095 0.02 DBMET03692 0.122 0.007 DBMET03695 0.106 0.013 DBMET00934 | DBMET03695 | |
| 0.19 | 0.112 | 0.369 | Peptidyltransferase inhibitor | 0.184 0.122 DBMET03692 0.368 0.01 DBMET03696 0.263 0.042 DBMET00934 0.369 0.009 DBMET03693 | DBMET03693 | |
| 0.105 | 0.028 | 0.177 | Vanilloid agonist | 0.105 0.029 DBMET03692 0.08 0.07 DBMET03696 0.177 0.008 DBMET00934 0.083 0.062 DBMET03693 | DBMET00934 | |
| 0.177 | 0.099 | 0.22 | Insulin sensitizer | 0.169 0.108 DBMET03692 0.22 0.055 DBMET03695 0.172 0.105 DBMET03696 0.159 0.12 DBMET00934 0.162 0.117 DBMET03693 | DBMET03695 | |
| 0.186 | 0.109 | 0.518 | Free radical scavenger | 0.223 0.082 DBMET03692 0.454 0.021 DBMET03696 0.197 0.1 DBMET00934 0.518 0.014 DBMET03693 | DBMET03693 | |
| 0.15 | 0.074 | 0.155 | Phospholipase A2 inhibitor | 0.143 0.082 DBMET03692 0.155 0.069 DBMET03695 0.132 0.098 DBMET03696 0.15 0.074 DBMET00934 0.127 0.106 DBMET03693 | DBMET03695 | |
| 0.142 | 0.066 | 0.143 | Ca2+-transporting ATPase inhibitor | 0.143 0.063 DBMET03692 0.137 0.083 DBMET03696 0.133 0.104 DBMET00934 0.135 0.095 DBMET03693 | DBMET03692 | |
| 0.161 | 0.089 | 0.176 | Amyloid beta precursor protein antagonist | 0.165 0.086 DBMET03692 0.176 0.075 DBMET03695 | DBMET03695 | |
| 0.111 | 0.04 | 0.111 | Calcium antagonist | 0.086 0.059 DBMET03692 | ||
| 0.069 | 0.002 | 0.069 | Estrogen-related receptor gamma agonist | 0.047 0.003 DBMET03692 0.062 0.002 DBMET00934 | ||
| 0.109 | 0.043 | 0.115 | Lanosterol 14 alpha demethylase inhibitor | 0.097 0.06 DBMET03692 0.115 0.036 DBMET00934 | DBMET00934 | |
| 0.097 | 0.031 | 0.195 | Purinergic P2X2 antagonist | 0.115 0.023 DBMET03692 0.195 0.005 DBMET03695 | DBMET03695 | |
| 0.098 | 0.033 | 0.124 | Na+ K+ transporting ATPase inhibitor | 0.104 0.028 DBMET03692 0.121 0.016 DBMET03696 0.124 0.014 DBMET03693 | DBMET03693 | |
| 0.13 | 0.065 | 0.13 | Cholinergic antagonist | 0.121 0.073 DBMET03692 | ||
| 0.125 | 0.062 | 0.125 | Acetylcholine muscarinic antagonist | 0.114 0.073 DBMET03692 0.106 0.083 DBMET03695 | ||
| 0.115 | 0.054 | 0.119 | Electron transport complex I inhibitor | 0.119 0.049 DBMET03692 0.119 0.048 DBMET00934 | DBMET00934 | |
| 0.139 | 0.078 | 0.148 | Heat shock protein 70 antagonist | 0.138 0.084 DBMET03692 0.143 0.064 DBMET03696 0.148 0.051 DBMET03693 | DBMET03693 | |
| 0.14 | 0.079 | 0.149 | Sphingosine 1-phosphate receptor 5 antagonist | 0.149 0.063 DBMET03692 0.122 0.119 DBMET03695 0.124 0.115 DBMET00934 | DBMET03692 | |
| 0.138 | 0.077 | 0.297 | Lipid peroxidase inhibitor | 0.161 0.061 DBMET03692 0.158 0.063 DBMET03695 0.249 0.027 DBMET03696 0.297 0.019 DBMET03693 | DBMET03693 | |
| 0.115 | 0.055 | 0.235 | Aminopeptidase B inhibitor | 0.11 0.058 DBMET03692 0.235 0.015 DBMET03695 0.116 0.055 DBMET00934 | DBMET03695 | |
| 0.103 | 0.043 | 0.106 | Bile acid receptor antagonist | 0.106 0.037 DBMET03692 0.1 0.048 DBMET00934 | DBMET03692 | |
| 0.102 | 0.042 | 0.13 | Ornithine decarboxylase inhibitor | 0.104 0.04 DBMET03692 0.078 0.07 DBMET03696 0.13 0.019 DBMET00934 0.077 0.071 DBMET03693 | DBMET00934 | |
| 0.14 | 0.08 | 0.14 | Thiol protease inhibitor | 0.138 0.083 DBMET03692 0.13 0.095 DBMET00934 | ||
| 0.123 | 0.065 | 0.15 | Adenylate cyclase inhibitor | 0.104 0.081 DBMET03692 0.15 0.045 DBMET03695 0.13 0.06 DBMET00934 | DBMET03695 | |
| 0.061 | 0.003 | 0.061 | Estrogen-related receptor gamma antagonist | 0.051 0.003 DBMET03692 0.028 0.021 DBMET03695 0.049 0.004 DBMET00934 | ||
| 0.066 | 0.01 | 0.067 | Dopamine D5 agonist | 0.057 0.013 DBMET03692 0.067 0.009 DBMET00934 | DBMET00934 | |
| 0.108 | 0.052 | 0.122 | Anabolic | 0.122 0.038 DBMET03692 0.093 0.073 DBMET00934 | DBMET03692 | |
| 0.096 | 0.04 | 0.121 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.103 0.036 DBMET03692 0.121 0.029 DBMET03695 | DBMET03695 | |
| 0.067 | 0.012 | 0.068 | Oxytocin agonist | 0.066 0.012 DBMET03692 0.056 0.02 DBMET03695 0.068 0.011 DBMET00934 | DBMET00934 | |
| 0.184 | 0.129 | 0.239 | DNA damaging | 0.205 0.111 DBMET03692 0.237 0.088 DBMET03695 0.209 0.108 DBMET03696 0.239 0.087 DBMET03693 | DBMET03693 | |
| 0.193 | 0.139 | 0.193 | 5 Hydroxytryptamine 1E antagonist | 0.18 0.154 DBMET00934 | ||
| 0.121 | 0.067 | 0.29 | Alkylator | 0.141 0.052 DBMET03692 0.167 0.038 DBMET03695 0.238 0.018 DBMET03696 0.29 0.013 DBMET03693 | DBMET03693 | |
| 0.114 | 0.06 | 0.124 | Chelator | 0.124 0.05 DBMET03692 0.123 0.051 DBMET00934 | DBMET03692 | |
| 0.175 | 0.121 | 0.176 | 5 Hydroxytryptamine 3E antagonist | 0.164 0.155 DBMET03692 0.176 0.117 DBMET00934 | DBMET00934 | |
| 0.102 | 0.048 | 0.146 | Phosphodiesterase 6D inhibitor | 0.099 0.054 DBMET03692 0.146 0.011 DBMET03696 0.143 0.012 DBMET03693 | DBMET03696 | |
| 0.068 | 0.014 | 0.068 | CXC chemokine 1 receptor antagonist | 0.067 0.014 DBMET03692 0.05 0.037 DBMET00934 | ||
| 0.202 | 0.149 | 0.236 | 12-Lipoxygenase inhibitor | 0.199 0.153 DBMET03692 0.236 0.117 DBMET00934 | DBMET00934 | |
| 0.085 | 0.033 | 0.105 | Glycine receptor agonist | 0.105 0.018 DBMET03692 0.076 0.044 DBMET03695 0.076 0.045 DBMET03696 0.07 0.055 DBMET00934 0.088 0.03 DBMET03693 | DBMET03692 | |
| 0.119 | 0.066 | 0.155 | Proteasome inhibitor | 0.122 0.064 DBMET03692 0.155 0.043 DBMET00934 | DBMET00934 | |
| 0.148 | 0.097 | 0.393 | Nitric oxide antagonist | 0.174 0.079 DBMET03692 0.351 0.032 DBMET03696 0.133 0.115 DBMET00934 0.393 0.026 DBMET03693 | DBMET03693 | |
| 0.116 | 0.065 | 0.158 | Microtubule formation inhibitor | 0.12 0.06 DBMET03692 0.158 0.033 DBMET03696 0.107 0.079 DBMET00934 0.147 0.039 DBMET03693 | DBMET03696 | |
| 0.093 | 0.044 | 0.093 | Acetylcholine nicotinic antagonist | 0.093 0.044 DBMET03692 0.081 0.053 DBMET00934 | ||
| 0.106 | 0.059 | 0.112 | Carbonic anhydrase XV inhibitor | 0.112 0.053 DBMET03692 | DBMET03692 | |
| 0.118 | 0.072 | 0.118 | Acetylcholine antagonist | 0.109 0.081 DBMET03692 | ||
| 0.087 | 0.043 | 0.087 | Ca(v)3.1 blocker | 0.086 0.045 DBMET03692 0.077 0.071 DBMET00934 | ||
| 0.177 | 0.137 | 0.595 | Hypoglycemic | 0.195 0.117 DBMET03692 0.579 0.009 DBMET03696 0.595 0.008 DBMET03693 | DBMET03693 | |
| 0.207 | 0.17 | 0.42 | Apoptosis antagonist | 0.228 0.149 DBMET03692 0.396 0.039 DBMET03696 0.193 0.19 DBMET00934 0.42 0.033 DBMET03693 | DBMET03693 | |
| 0.086 | 0.05 | 0.094 | Opioid kappa receptor antagonist | 0.08 0.057 DBMET03692 0.094 0.041 DBMET00934 | DBMET00934 | |
| 0.1 | 0.064 | 0.104 | Folate antagonist | 0.099 0.067 DBMET03692 0.104 0.058 DBMET03696 0.101 0.063 DBMET00934 0.099 0.066 DBMET03693 | DBMET03696 | |
| 0.079 | 0.043 | 0.082 | Aminopeptidase I inhibitor | 0.078 0.044 DBMET03692 0.082 0.04 DBMET00934 | DBMET00934 | |
| 0.092 | 0.056 | 0.099 | Glutamate release inhibitor | 0.087 0.07 DBMET03692 0.099 0.044 DBMET03696 0.093 0.055 DBMET00934 0.086 0.073 DBMET03693 | DBMET03696 | |
| 0.068 | 0.032 | 0.068 | Calcium channel P-type blocker | 0.06 0.057 DBMET03692 | ||
| 0.175 | 0.14 | 0.199 | Nitric-oxide synthase stimulant | 0.192 0.102 DBMET03692 0.174 0.143 DBMET03696 0.198 0.093 DBMET00934 0.199 0.09 DBMET03693 | DBMET03693 | |
| 0.1 | 0.069 | 0.321 | Expectorant | 0.101 0.067 DBMET03692 0.156 0.033 DBMET03695 0.312 0.008 DBMET03696 0.094 0.076 DBMET00934 0.321 0.007 DBMET03693 | DBMET03693 | |
| 0.046 | 0.015 | 0.046 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.045 0.015 DBMET03692 | ||
| 0.056 | 0.026 | 0.062 | Antiviral (Hepatitis D) | 0.062 0.02 DBMET03692 | DBMET03692 | |
| 0.035 | 0.006 | 0.062 | Vanilloid 2 agonist | 0.039 0.004 DBMET03692 0.056 0.002 DBMET03696 0.034 0.006 DBMET00934 0.062 0.002 DBMET03693 | DBMET03693 | |
| 0.056 | 0.027 | 0.056 | Glycine transporter 2 inhibitor | |||
| 0.181 | 0.152 | 0.34 | DNA synthesis inhibitor | 0.199 0.124 DBMET03692 0.237 0.076 DBMET03695 0.321 0.037 DBMET03696 0.34 0.032 DBMET03693 | DBMET03693 | |
| 0.117 | 0.088 | 0.13 | Bone formation stimulant | 0.118 0.087 DBMET03692 0.105 0.1 DBMET03696 0.13 0.076 DBMET00934 0.119 0.087 DBMET03693 | DBMET00934 | |
| 0.098 | 0.07 | 0.127 | Urease inhibitor | 0.102 0.065 DBMET03692 0.127 0.039 DBMET03695 0.095 0.073 DBMET00934 | DBMET03695 | |
| 0.101 | 0.074 | 0.112 | DOPA decarboxylase inhibitor | 0.112 0.055 DBMET03692 0.096 0.084 DBMET00934 | DBMET03692 | |
| 0.058 | 0.03 | 0.069 | Immunoglobulin Fc receptor antagonist | 0.053 0.046 DBMET03692 0.069 0.012 DBMET00934 | DBMET00934 | |
| 0.068 | 0.042 | 0.068 | Opioid delta receptor antagonist | 0.061 0.046 DBMET03692 0.061 0.045 DBMET00934 | ||
| 0.052 | 0.027 | 0.055 | Dopamine beta hydroxylase inhibitor | 0.048 0.036 DBMET03692 0.055 0.022 DBMET00934 | DBMET00934 | |
| 0.038 | 0.013 | 0.038 | Estrogen-related receptor beta antagonist | 0.037 0.014 DBMET03692 | ||
| 0.046 | 0.022 | 0.046 | Liver X receptor alpha agonist | 0.039 0.031 DBMET03692 | ||
| 0.048 | 0.024 | 0.05 | Geranyltranstransferase inhibitor | 0.047 0.026 DBMET03692 0.05 0.023 DBMET00934 | DBMET00934 | |
| 0.122 | 0.099 | 0.139 | Farnesoid X receptor antagonist | 0.139 0.068 DBMET03692 0.119 0.105 DBMET00934 | DBMET03692 | |
| 0.063 | 0.04 | 0.063 | Prolactin release inhibitor | 0.063 0.041 DBMET03692 | ||
| 0.073 | 0.05 | 0.073 | Cathepsin G inhibitor | 0.067 0.058 DBMET03692 0.064 0.063 DBMET00934 | ||
| 0.065 | 0.043 | 0.072 | Beta 3 adrenoreceptor antagonist | 0.072 0.031 DBMET00934 | DBMET00934 | |
| 0.099 | 0.077 | 0.31 | Monophenol monooxygenase inhibitor | 0.105 0.072 DBMET03692 0.232 0.027 DBMET03696 0.104 0.073 DBMET00934 0.31 0.017 DBMET03693 | DBMET03693 | |
| 0.088 | 0.067 | 0.133 | Alcohol dehydrogenase inhibitor | 0.096 0.057 DBMET03692 0.133 0.027 DBMET03695 0.088 0.067 DBMET03693 | DBMET03695 | |
| 0.084 | 0.063 | 0.084 | Histamine N-methyltransferase inhibitor | |||
| 0.105 | 0.086 | 0.129 | Interleukin 8 antagonist | 0.105 0.085 DBMET03692 0.129 0.051 DBMET00934 | DBMET00934 | |
| 0.073 | 0.057 | 0.078 | Vanilloid 4 agonist | 0.073 0.056 DBMET03692 0.078 0.045 DBMET00934 | DBMET00934 | |
| 0.033 | 0.017 | 0.033 | Liver X receptor beta antagonist | |||
| 0.086 | 0.07 | 0.18 | HIV-1 integrase (Overall Integration) inhibitor | 0.081 0.077 DBMET03692 0.18 0.016 DBMET03695 | DBMET03695 | |
| 0.059 | 0.043 | 0.059 | Bcl-xL inhibitor | 0.057 0.052 DBMET03692 | ||
| 0.054 | 0.038 | 0.066 | Acyl-CoA dehydrogenase inhibitor | 0.066 0.029 DBMET03692 | DBMET03692 | |
| 0.03 | 0.015 | 0.03 | Urotensin II agonist | 0.029 0.016 DBMET03692 | ||
| 0.058 | 0.044 | 0.063 | Cathepsin E inhibitor | 0.056 0.046 DBMET03692 0.063 0.036 DBMET00934 | DBMET00934 | |
| 0.142 | 0.128 | 0.634 | Angiogenesis stimulant | 0.173 0.109 DBMET03692 0.604 0.007 DBMET03696 0.155 0.12 DBMET00934 0.634 0.005 DBMET03693 | DBMET03693 | |
| 0.049 | 0.036 | 0.096 | Factor III inhibitor | 0.047 0.043 DBMET03692 0.057 0.021 DBMET03696 0.096 0.005 DBMET00934 0.058 0.02 DBMET03693 | DBMET00934 | |
| 0.068 | 0.055 | 0.068 | Calcium channel L-type blocker | 0.066 0.059 DBMET00934 | ||
| 0.029 | 0.016 | 0.029 | Hedgehog signaling activator | 0.027 0.02 DBMET03692 | ||
| 0.083 | 0.071 | 0.124 | ATPase (Vacuolar H+) inhibitor | 0.124 0.017 DBMET03696 0.09 0.056 DBMET00934 0.12 0.019 DBMET03693 | DBMET03696 | |
| 0.074 | 0.062 | 0.098 | Interferon agonist | 0.076 0.06 DBMET03692 0.098 0.03 DBMET03696 0.086 0.044 DBMET03693 | DBMET03696 | |
| 0.03 | 0.017 | 0.032 | Vasopressin 1A agonist | 0.03 0.017 DBMET03692 0.032 0.012 DBMET00934 | DBMET00934 | |
| 0.06 | 0.049 | 0.068 | Beta 2 adrenoreceptor agonist | 0.068 0.024 DBMET00934 | DBMET00934 | |
| 0.122 | 0.112 | 0.122 | Sigma receptor agonist | |||
| 0.125 | 0.115 | 0.125 | Pregnane X receptor agonist | |||
| 0.053 | 0.044 | 0.053 | 5 Hydroxytryptamine 7 agonist | |||
| 0.039 | 0.03 | 0.039 | Erythropoietin receptor agonist | 0.036 0.033 DBMET03692 0.036 0.033 DBMET00934 | ||
| 0.052 | 0.044 | 0.079 | Epithelial sodium channel blocker | 0.079 0.013 DBMET03695 | DBMET03695 | |
| 0.05 | 0.047 | 0.051 | Angiotensin-converting enzyme inhibitor | 0.051 0.045 DBMET03692 0.05 0.047 DBMET00934 | DBMET03692 | |
| 0.041 | 0.038 | 0.049 | Histamine H1 receptor agonist | 0.049 0.02 DBMET00934 | DBMET00934 | |
| 0.047 | 0.043 | 0.061 | Ribonucleoside-diphosphate reductase inhibitor | 0.047 0.043 DBMET03692 0.061 0.034 DBMET00934 | DBMET00934 | |
| 0.097 | 0.094 | 0.106 | Acetylcholine release stimulant | 0.106 0.075 DBMET03696 | DBMET03696 | |
| 0.014 | 0.012 | 0.015 | Thyroid hormone alpha antagonist | 0.015 0.011 DBMET03692 | DBMET03692 | |
| 0.045 | 0.043 | 0.051 | Bombesin 2 receptor antagonist | 0.046 0.041 DBMET03692 0.051 0.032 DBMET00934 | DBMET00934 | |
| 0.039 | 0.038 | 0.048 | Neurotensin receptor antagonist | 0.039 0.038 DBMET03692 0.048 0.029 DBMET00934 | DBMET00934 | |
| 0.02 | 0.019 | 0.02 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.033 | 0.032 | 0.033 | Kinesin antagonist | |||
| 0.033 | 0.032 | 0.033 | Kinesin-like protein 1 inhibitor | |||
| 0.106 | 0.106 | 0.136 | Calcium channel blocker | 0.136 0.071 DBMET03695 | DBMET03695 | |
| 0.046 | 0.045 | 0.062 | Ribonucleotide reductase inhibitor | 0.046 0.045 DBMET03692 0.062 0.035 DBMET00934 | DBMET00934 | |
| 0.019 | 0.02 | 0.022 | Neuraminidase (Influenza B) inhibitor | 0.022 0.013 DBMET03692 | DBMET03692 | |
| 0.084 | 0.084 | 0.1 | Interleukin 1 beta converting enzyme inhibitor | 0.1 0.058 DBMET00934 | DBMET00934 | |
| 0.124 | 0.125 | 0.245 | Interferon gamma antagonist | 0.13 0.112 DBMET03692 0.214 0.036 DBMET03696 0.245 0.029 DBMET03693 | DBMET03693 | |
| 0.121 | 0.122 | 0.127 | Neuropeptide Y1 antagonist | 0.127 0.106 DBMET00934 | DBMET00934 | |
| 0.02 | 0.021 | 0.022 | Vasopressin 1 agonist | 0.022 0.015 DBMET00934 | DBMET00934 | |
| 0.063 | 0.065 | 0.073 | Glutamate decarboxylase inhibitor | 0.073 0.052 DBMET03692 | DBMET03692 | |
| 0.025 | 0.026 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.019 DBMET00934 | DBMET00934 | |
| 0.033 | 0.036 | 0.043 | Delayed rectifier potassium channel blocker | 0.043 0.018 DBMET00934 | DBMET00934 | |
| 0.026 | 0.029 | 0.032 | Estrogen receptor alpha agonist | 0.032 0.025 DBMET03692 | DBMET03692 | |
| 0.023 | 0.026 | 0.024 | Thyroid hormone agonist | 0.024 0.023 DBMET00934 | DBMET00934 | |
| 0.204 | 0.207 | 0.307 | Calcium channel activator | 0.301 0.091 DBMET03695 0.307 0.085 DBMET00934 | DBMET00934 | |
| 0.022 | 0.026 | 0.025 | Lysine carboxypeptidase inhibitor | 0.025 0.021 DBMET00934 | DBMET00934 | |
| 0.024 | 0.028 | 0.027 | Antidiuretic hormone agonist | 0.027 0.019 DBMET00934 | DBMET00934 | |
| 0.047 | 0.051 | 0.048 | Vanilloid 2 antagonist | 0.048 0.047 DBMET00934 | DBMET00934 | |
| 0.014 | 0.019 | 0.017 | Nicotinic acid receptor 1 antagonist | 0.017 0.013 DBMET00934 | DBMET00934 | |
| 0.105 | 0.11 | 0.144 | Interleukin 4 antagonist | 0.122 0.083 DBMET03692 0.115 0.093 DBMET03696 0.144 0.056 DBMET03693 | DBMET03693 | |
| 0.013 | 0.018 | 0.038 | Ileal bile acid transport inhibitor | 0.037 0.004 DBMET03696 0.038 0.004 DBMET03693 | DBMET03693 | |
| 0.032 | 0.039 | 0.035 | Oxytocin antagonist | 0.035 0.033 DBMET03692 | DBMET03692 | |
| 0.087 | 0.095 | 0.161 | Toll-Like receptor 4 antagonist | 0.158 0.017 DBMET03696 0.161 0.016 DBMET03693 | DBMET03693 | |
| 0.086 | 0.095 | 0.101 | Cystathionine beta-synthase inhibitor | 0.101 0.075 DBMET03692 0.1 0.076 DBMET03693 | DBMET03692 | |
| 0.037 | 0.047 | 0.045 | Potassium channel Kv1.3 blocker | 0.045 0.035 DBMET00934 | DBMET00934 | |
| 0.028 | 0.038 | 0.032 | Glutamate (mGluR3) agonist | 0.032 0.022 DBMET00934 | DBMET00934 | |
| 0.055 | 0.065 | 0.093 | Phenylalanine 4-hydroxylase inhibitor | 0.093 0.029 DBMET00934 | DBMET00934 | |
| 0.086 | 0.097 | 0.166 | GABA receptor agonist | 0.166 0.028 DBMET03695 | DBMET03695 | |
| 0.061 | 0.072 | 0.07 | Glutamate dehydrogenase inhibitor | 0.065 0.064 DBMET03692 0.068 0.059 DBMET03695 0.07 0.057 DBMET00934 | DBMET00934 | |
| 0.055 | 0.067 | 0.068 | Histone deacetylase SIRT3 inhibitor | 0.068 0.03 DBMET00934 | DBMET00934 | |
| 0.126 | 0.14 | 0.401 | Hepatoprotectant | 0.152 0.107 DBMET03692 0.373 0.016 DBMET03696 0.401 0.013 DBMET03693 | DBMET03693 | |
| 0.129 | 0.143 | 0.136 | Lipocortins synthesis antagonist | 0.135 0.13 DBMET03692 0.136 0.128 DBMET03696 | DBMET03696 | |
| 0.055 | 0.069 | 0.07 | Interferon inducer | 0.07 0.035 DBMET03696 0.06 0.054 DBMET03693 | DBMET03696 | |
| 0.064 | 0.08 | 0.072 | Phosphodiesterase VI inhibitor | 0.071 0.06 DBMET03696 0.072 0.057 DBMET03693 | DBMET03693 | |
| 0.043 | 0.061 | 0.06 | Leukotriene B4 antagonist | 0.059 0.029 DBMET03696 0.06 0.028 DBMET03693 | DBMET03693 | |
| 0.107 | 0.126 | 0.297 | Thrombolytic | 0.294 0.025 DBMET03696 0.297 0.024 DBMET03693 | DBMET03693 | |
| 0.077 | 0.096 | 0.207 | Mediator release inhibitor | 0.181 0.018 DBMET03696 0.088 0.084 DBMET00934 0.207 0.014 DBMET03693 | DBMET03693 | |
| 0.052 | 0.071 | 0.083 | Beta adrenoreceptor antagonist | 0.083 0.025 DBMET00934 | DBMET00934 | |
| 0.027 | 0.046 | 0.031 | Melatonin receptor 1A agonist | 0.031 0.028 DBMET00934 | DBMET00934 | |
| 0.059 | 0.08 | 0.186 | CDC25A inhibitor | 0.069 0.059 DBMET03692 0.186 0.008 DBMET03695 | DBMET03695 | |
| 0.022 | 0.043 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.018 DBMET03696 0.031 0.014 DBMET03693 | DBMET03693 | |
| 0.046 | 0.066 | 0.072 | Sphingosine 1-phosphate receptor 3 antagonist | 0.072 0.023 DBMET03695 | DBMET03695 | |
| 0.053 | 0.074 | 0.058 | Heme oxygenase stimulant | 0.058 0.051 DBMET00934 | DBMET00934 | |
| 0.026 | 0.049 | 0.031 | Carboxypeptidase B inhibitor | 0.031 0.026 DBMET00934 | DBMET00934 | |
| 0.076 | 0.1 | 0.083 | Protein kinase C zeta inhibitor | 0.083 0.08 DBMET03695 | DBMET03695 | |
| 0.009 | 0.034 | 0.017 | KiSS-1 receptor antagonist | 0.017 0.012 DBMET00934 | DBMET00934 | |
| 0.065 | 0.09 | 0.08 | NMDA receptor antagonist | 0.08 0.065 DBMET00934 | DBMET00934 | |
| 0.132 | 0.158 | 0.287 | Hypolipemic | 0.287 0.053 DBMET03696 0.284 0.054 DBMET03693 | DBMET03696 | |
| 0.044 | 0.07 | 0.073 | Bombesin 1 receptor agonist | 0.073 0.03 DBMET00934 | DBMET00934 | |
| 0.068 | 0.094 | 0.092 | Histamine H2 receptor antagonist | 0.092 0.043 DBMET00934 | DBMET00934 | |
| 0.031 | 0.057 | 0.045 | Histamine H2 receptor agonist | 0.045 0.026 DBMET00934 | DBMET00934 | |
| 0.167 | 0.195 | 0.225 | Hypoxia-inducible factor 1 alpha inhibitor | 0.18 0.178 DBMET03695 0.193 0.16 DBMET03696 0.225 0.124 DBMET03693 | DBMET03693 | |
| 0.105 | 0.133 | 0.127 | Papain-like protease (SARS coronavirus) inhibitor | 0.127 0.065 DBMET00934 | DBMET00934 | |
| 0.03 | 0.059 | 0.059 | NMDA 2A receptor antagonist | 0.059 0.03 DBMET00934 | DBMET00934 | |
| 0.015 | 0.044 | 0.045 | Squalene synthetase inhibitor | 0.037 0.019 DBMET03695 0.045 0.016 DBMET03696 0.038 0.019 DBMET03693 | DBMET03696 | |
| 0.034 | 0.064 | 0.064 | Beta 2 adrenoreceptor antagonist | 0.064 0.02 DBMET00934 | DBMET00934 | |
| 0.04 | 0.07 | 0.086 | Glucose-6-phosphate translocase inhibitor | 0.083 0.01 DBMET03696 0.086 0.009 DBMET03693 | DBMET03693 | |
| 0.011 | 0.041 | 0.017 | Telomerase stimulant | 0.017 0.013 DBMET03693 | DBMET03693 | |
| 0.029 | 0.059 | 0.04 | Guanylate cyclase inhibitor | 0.04 0.034 DBMET03696 | DBMET03696 | |
| 0.014 | 0.046 | 0.023 | Dopamine D1 agonist | 0.021 0.018 DBMET03696 0.023 0.016 DBMET03693 | DBMET03693 | |
| 0.096 | 0.128 | 0.177 | Histone deacetylase SIRT1 inhibitor | 0.177 0.041 DBMET03695 0.142 0.069 DBMET00934 | DBMET03695 | |
| 0.009 | 0.041 | 0.029 | Neutral endopeptidase inhibitor | 0.029 0.012 DBMET03695 | DBMET03695 | |
| 0.013 | 0.048 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.009 DBMET03696 0.021 0.01 DBMET03693 | DBMET03693 | |
| 0.111 | 0.147 | 0.15 | GABA C receptor rho-2 antagonist | 0.131 0.103 DBMET03692 0.15 0.074 DBMET00934 | DBMET00934 | |
| 0.116 | 0.154 | 0.128 | CF transmembrane conductance regulator agonist | 0.128 0.124 DBMET03692 | DBMET03692 | |
| 0.052 | 0.09 | 0.155 | Topoisomerase II alpha inhibitor | 0.115 0.032 DBMET03696 0.155 0.022 DBMET03693 | DBMET03693 | |
| 0.06 | 0.1 | 0.106 | Glycine receptor antagonist | 0.106 0.028 DBMET03696 0.097 0.036 DBMET03693 | DBMET03696 | |
| 0.032 | 0.073 | 0.099 | Protein 50S ribosomal subunit inhibitor | 0.099 0.013 DBMET03696 0.098 0.014 DBMET03693 | DBMET03696 | |
| 0.089 | 0.132 | 0.209 | Cathepsin H inhibitor | 0.209 0.02 DBMET03695 | DBMET03695 | |
| 0.044 | 0.087 | 0.056 | Heat shock protein 90 beta antagonist | 0.056 0.047 DBMET03692 | DBMET03692 | |
| 0.071 | 0.114 | 0.091 | GABA C receptor agonist | 0.091 0.077 DBMET03692 | DBMET03692 | |
| 0.078 | 0.125 | 0.231 | Adenylate kinase inhibitor | 0.231 0.011 DBMET03695 | DBMET03695 | |
| 0.081 | 0.129 | 0.1 | Caspase 3 inhibitor | 0.1 0.091 DBMET03695 | DBMET03695 | |
| 0.07 | 0.119 | 0.189 | Protein-tyrosine phosphatase 1B inhibitor | 0.189 0.032 DBMET03695 0.105 0.074 DBMET03696 0.124 0.06 DBMET03693 | DBMET03695 | |
| 0.033 | 0.083 | 0.069 | Beta 1 adrenoreceptor antagonist | 0.069 0.027 DBMET00934 | DBMET00934 | |
| 0.029 | 0.08 | 0.055 | Neuraminidase (Influenza A) inhibitor | 0.054 0.019 DBMET03696 0.055 0.017 DBMET03693 | DBMET03693 | |
| 0.012 | 0.063 | 0.056 | Arginase inhibitor | 0.042 0.02 DBMET03696 0.056 0.012 DBMET03693 | DBMET03693 | |
| 0.03 | 0.081 | 0.042 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.042 0.028 DBMET03695 | DBMET03695 | |
| 0.035 | 0.088 | 0.078 | Alpha-mannosidase inhibitor | 0.06 0.026 DBMET03695 0.078 0.012 DBMET03696 0.072 0.016 DBMET03693 | DBMET03696 | |
| 0.037 | 0.09 | 0.069 | Carbonic anhydrase stimulant | 0.069 0.032 DBMET00934 | DBMET00934 | |
| 0.038 | 0.092 | 0.134 | Phosphofructokinase-1 inhibitor | 0.134 0.022 DBMET03695 0.099 0.032 DBMET03696 0.104 0.03 DBMET03693 | DBMET03695 | |
| 0.094 | 0.15 | 0.363 | Diuretic | 0.363 0.015 DBMET03695 0.213 0.039 DBMET03696 0.206 0.042 DBMET03693 | DBMET03695 | |
| 0.034 | 0.089 | 0.055 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.055 0.036 DBMET03695 | DBMET03695 | |
| 0.043 | 0.099 | 0.061 | Adenine nucleotide translocase inhibitor | 0.061 0.027 DBMET03696 0.06 0.028 DBMET03693 | DBMET03696 | |
| 0.04 | 0.098 | 0.184 | Antineoplastic antibiotic | 0.166 0.027 DBMET03696 0.184 0.024 DBMET03693 | DBMET03693 | |
| 0.045 | 0.104 | 0.063 | Lipocortins synthesis agonist | 0.063 0.03 DBMET03696 0.062 0.033 DBMET03693 | DBMET03696 | |
| 0.025 | 0.084 | 0.074 | Ornithine carbamoyltransferase inhibitor | 0.074 0.024 DBMET03695 | DBMET03695 | |
| 0.073 | 0.133 | 0.135 | M18 aspartyl aminopeptidase inhibitor | 0.135 0.06 DBMET00934 | DBMET00934 | |
| 0.031 | 0.092 | 0.05 | Glucose-6-phosphate isomerase inhibitor | 0.05 0.03 DBMET03695 0.047 0.035 DBMET03696 0.046 0.036 DBMET03693 | DBMET03695 | |
| 0.068 | 0.129 | 0.13 | DNA intercalator | 0.125 0.055 DBMET03696 0.13 0.052 DBMET03693 | DBMET03693 | |
| 0.042 | 0.105 | 0.125 | Porphobilinogen synthase inhibitor | 0.125 0.027 DBMET03695 | DBMET03695 | |
| 0.092 | 0.157 | 0.271 | Cell wall synthesis inhibitor | 0.125 0.093 DBMET03695 0.241 0.018 DBMET03696 0.271 0.013 DBMET03693 | DBMET03693 | |
| 0.072 | 0.138 | 0.343 | Amylase inhibitor | 0.273 0.022 DBMET03696 0.343 0.014 DBMET03693 | DBMET03693 | |
| 0.012 | 0.078 | 0.046 | Protein 30S ribosomal subunit inhibitor | 0.042 0.009 DBMET03696 0.046 0.009 DBMET03693 | DBMET03693 | |
| 0.088 | 0.158 | 0.112 | Antibacterial (Helicobacter pylori) | 0.112 0.095 DBMET00934 | DBMET00934 | |
| 0.03 | 0.1 | 0.068 | HIV-1 integrase (Strand Transfer) inhibitor | 0.068 0.037 DBMET03695 | DBMET03695 | |
| 0.096 | 0.167 | 0.121 | Heat shock protein 90 antagonist | 0.121 0.111 DBMET03692 | DBMET03692 | |
| 0.107 | 0.181 | 0.197 | Interleukin 6 antagonist | 0.19 0.047 DBMET03696 0.197 0.042 DBMET03693 | DBMET03693 | |
| 0.09 | 0.166 | 0.333 | Protein-tyrosine phosphatase inhibitor | 0.333 0.014 DBMET03695 0.133 0.098 DBMET03693 | DBMET03695 | |
| 0.066 | 0.141 | 0.093 | GABA C receptor rho-1 antagonist | 0.093 0.074 DBMET00934 | DBMET00934 | |
| 0.063 | 0.139 | 0.112 | Thioredoxin inhibitor | 0.104 0.044 DBMET03696 0.112 0.036 DBMET03693 | DBMET03693 | |
| 0.074 | 0.153 | 0.139 | Alpha-N-acetylglucosaminidase inhibitor | 0.139 0.062 DBMET03696 0.123 0.075 DBMET03693 | DBMET03696 | |
| 0.009 | 0.089 | 0.026 | Uridine phosphorylase inhibitor | 0.026 0.021 DBMET03695 | DBMET03695 | |
| 0.035 | 0.118 | 0.074 | HIV-1 integrase (3'-Processing) inhibitor | 0.074 0.036 DBMET03695 | DBMET03695 | |
| 0.005 | 0.089 | 0.023 | Prostaglandin H2 antagonist | 0.023 0.02 DBMET03695 | DBMET03695 | |
| 0.052 | 0.139 | 0.087 | GABA A receptor agonist | 0.087 0.052 DBMET03695 | DBMET03695 | |
| 0.021 | 0.108 | 0.066 | Mannosidase inhibitor | 0.046 0.03 DBMET03695 0.066 0.013 DBMET03696 0.056 0.02 DBMET03693 | DBMET03696 | |
| 0.057 | 0.146 | 0.161 | Triose-phosphate isomerase inhibitor | 0.161 0.017 DBMET03695 0.105 0.043 DBMET03696 0.082 0.072 DBMET03693 | DBMET03695 | |
| 0.012 | 0.102 | 0.046 | Sodium/glucose cotransporter inhibitor | 0.046 0.005 DBMET03696 0.045 0.006 DBMET03693 | DBMET03696 | |
| 0.022 | 0.112 | 0.044 | Carbonic anhydrase XIV inhibitor | 0.044 0.041 DBMET03693 | DBMET03693 | |
| 0.016 | 0.108 | 0.046 | Dihydropteroate synthase inhibitor | 0.046 0.02 DBMET03695 | DBMET03695 | |
| 0.05 | 0.143 | 0.199 | Topoisomerase I inhibitor | 0.168 0.035 DBMET03696 0.199 0.027 DBMET03693 | DBMET03693 | |
| 0.018 | 0.111 | 0.039 | Angiotensin AT1 receptor antagonist | 0.039 0.034 DBMET03695 | DBMET03695 | |
| 0.024 | 0.118 | 0.058 | AICAR transformylase inhibitor | 0.058 0.016 DBMET03695 | DBMET03695 | |
| 0.009 | 0.105 | 0.049 | Sodium/glucose cotransporter 2 inhibitor | 0.049 0.006 DBMET03696 0.047 0.007 DBMET03693 | DBMET03696 | |
| 0.021 | 0.12 | 0.067 | Antibiotic Aminoglycoside-like | 0.066 0.007 DBMET03696 0.067 0.007 DBMET03693 | DBMET03693 | |
| 0.045 | 0.144 | 0.083 | Adrenaline agonist | 0.083 0.054 DBMET00934 | DBMET00934 | |
| 0.034 | 0.138 | 0.084 | Neuraminidase (influenza) inhibitor | 0.066 0.041 DBMET03695 0.073 0.032 DBMET03696 0.084 0.023 DBMET03693 | DBMET03693 | |
| 0.056 | 0.161 | 0.106 | NADH dehydrogenase inhibitor | 0.106 0.038 DBMET03695 0.093 0.052 DBMET03696 0.091 0.055 DBMET03693 | DBMET03695 | |
| 0.089 | 0.197 | 0.225 | Insulin secretagoues | 0.225 0.025 DBMET03696 0.221 0.027 DBMET03693 | DBMET03696 | |
| 0.059 | 0.17 | 0.115 | Xanthine oxidase inhibitor | 0.084 0.083 DBMET03696 0.115 0.05 DBMET03693 | DBMET03693 | |
| 0.034 | 0.145 | 0.069 | Purinergic P2X1 antagonist | 0.069 0.033 DBMET03695 | DBMET03695 | |
| 0.016 | 0.128 | 0.032 | Dipeptidyl peptidase II inhibitor | 0.032 0.023 DBMET03695 | DBMET03695 | |
| 0.049 | 0.163 | 0.112 | Sphingosine 1-phosphate receptor antagonist | 0.112 0.016 DBMET03695 | DBMET03695 | |
| 0.133 | 0.248 | 0.177 | RNA-directed DNA polymerase inhibitor | 0.165 0.164 DBMET03692 0.177 0.139 DBMET03695 | DBMET03695 | |
| 0.023 | 0.138 | 0.079 | Neuraminidase inhibitor | 0.067 0.036 DBMET03696 0.079 0.026 DBMET03693 | DBMET03693 | |
| 0.065 | 0.182 | 0.101 | Glutamate (mGluR7) agonist | 0.101 0.058 DBMET00934 | DBMET00934 | |
| 0.182 | 0.303 | 0.51 | Apoptosis agonist | 0.462 0.087 DBMET03696 0.51 0.071 DBMET03693 | DBMET03693 | |
| 0.05 | 0.173 | 0.203 | Topoisomerase II inhibitor | 0.157 0.046 DBMET03696 0.203 0.033 DBMET03693 | DBMET03693 | |
| 0.089 | 0.212 | 0.368 | Hemostatic | 0.199 0.033 DBMET03695 0.343 0.012 DBMET03696 0.368 0.01 DBMET03693 | DBMET03693 | |
| 0.023 | 0.151 | 0.322 | Selectin antagonist | 0.32 0.005 DBMET03696 0.322 0.005 DBMET03693 | DBMET03693 | |
| 0.05 | 0.18 | 0.112 | UDP-glucose 4-epimerase inhibitor | 0.112 0.049 DBMET03696 0.103 0.057 DBMET03693 | DBMET03696 | |
| 0.087 | 0.218 | 0.46 | Dual specificity phosphatase inhibitor | 0.46 0.009 DBMET03695 | DBMET03695 | |
| 0.017 | 0.167 | 0.051 | Thromboxane antagonist | 0.051 0.04 DBMET03695 | DBMET03695 | |
| 0.065 | 0.216 | 0.224 | Cell adhesion inhibitor | 0.224 0.019 DBMET03696 0.214 0.021 DBMET03693 | DBMET03696 | |
| 0.058 | 0.21 | 0.161 | Toll-Like receptor 3 antagonist | 0.161 0.012 DBMET00934 | DBMET00934 | |
| 0.01 | 0.164 | 0.037 | Calcium-sensing receptor agonist | 0.037 0.009 DBMET03695 | DBMET03695 | |
| 0.029 | 0.186 | 0.066 | Sphingosine 1-phosphate receptor 1 antagonist | 0.066 0.021 DBMET03695 | DBMET03695 | |
| 0.014 | 0.171 | 0.048 | Thromboxane A2 antagonist | 0.048 0.038 DBMET03695 | DBMET03695 | |
| 0.053 | 0.213 | 0.102 | Multidrug resistance-associated protein 1 inhibitor | 0.102 0.075 DBMET03693 | DBMET03693 | |
| 0.101 | 0.266 | 0.136 | CC chemokine 6 receptor antagonist | 0.136 0.05 DBMET03696 0.135 0.052 DBMET03693 | DBMET03696 | |
| 0.049 | 0.219 | 0.119 | Histone deacetylase class III inhibitor | 0.119 0.07 DBMET03695 | DBMET03695 | |
| 0.036 | 0.209 | 0.076 | Inducible nitric-oxide synthase inhibitor | 0.076 0.07 DBMET00934 | DBMET00934 | |
| 0.009 | 0.184 | 0.032 | LFA antagonist | 0.032 0.013 DBMET03695 | DBMET03695 | |
| 0.072 | 0.25 | 0.189 | Hexokinase inhibitor | 0.169 0.058 DBMET03696 0.189 0.042 DBMET03693 | DBMET03693 | |
| 0.074 | 0.258 | 0.25 | NOS3 expression enhancer | 0.198 0.042 DBMET03696 0.25 0.026 DBMET03693 | DBMET03693 | |
| 0.072 | 0.286 | 0.149 | DNA repair enzyme inhibitor | 0.149 0.032 DBMET03696 0.142 0.039 DBMET03693 | DBMET03696 | |
| 0.019 | 0.236 | 0.057 | Nitric oxide donor | 0.057 0.055 DBMET03696 0.056 0.055 DBMET03693 | DBMET03696 | |
| 0.127 | 0.346 | 0.238 | Caspase 3 stimulant | 0.202 0.166 DBMET03696 0.238 0.124 DBMET03693 | DBMET03693 | |
| 0.076 | 0.3 | 0.347 | Tumour necrosis factor alpha release inhibitor | 0.34 0.041 DBMET03696 0.347 0.039 DBMET03693 | DBMET03693 | |
| 0.014 | 0.24 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.013 DBMET03696 0.029 0.014 DBMET03693 | DBMET03693 | |
| 0.022 | 0.254 | 0.077 | Heparanase inhibitor | 0.077 0.008 DBMET03696 0.072 0.01 DBMET03693 | DBMET03696 | |
| 0.046 | 0.279 | 0.114 | Transcription factor NF kappa B stimulant | 0.114 0.028 DBMET03696 0.112 0.03 DBMET03693 | DBMET03696 | |
| 0.062 | 0.303 | 0.13 | DNA methyltransferase I inhibitor | 0.13 0.129 DBMET03693 | DBMET03693 | |
| 0.036 | 0.283 | 0.109 | Cell adhesion molecule inhibitor | 0.109 0.029 DBMET03696 0.099 0.035 DBMET03693 | DBMET03696 | |
| 0.049 | 0.308 | 0.393 | Dual specificity phosphatase 3 inhibitor | 0.393 0.015 DBMET03695 | DBMET03695 | |
| 0.024 | 0.292 | 0.053 | Sodium/calcium exchanger inhibitor | 0.053 0.028 DBMET03695 | DBMET03695 | |
| 0.032 | 0.31 | 0.084 | Uric acid excretion stimulant | 0.084 0.075 DBMET03693 | DBMET03693 | |
| 0.034 | 0.315 | 0.115 | Beta glucuronidase inhibitor | 0.097 0.075 DBMET03696 0.115 0.05 DBMET03693 | DBMET03693 | |
| 0.005 | 0.292 | 0.045 | Purinergic P2X agonist | 0.045 0.011 DBMET03695 | DBMET03695 | |
| 0.121 | 0.423 | 0.679 | Cyclophilin D inhibitor | 0.672 0.017 DBMET03696 0.679 0.016 DBMET03693 | DBMET03693 | |
| 0.048 | 0.354 | 0.089 | Interleukin 12 antagonist | 0.089 0.076 DBMET03693 | DBMET03693 | |
| 0.004 | 0.335 | 0.077 | Follicle-stimulating hormone agonist | 0.077 0.004 DBMET03695 | DBMET03695 | |
| 0.028 | 0.364 | 0.133 | AMP-activated protein kinase stimulant | 0.117 0.052 DBMET03696 0.133 0.039 DBMET03693 | DBMET03693 | |
| 0.05 | 0.437 | 0.227 | Alpha-glucosidase inhibitor | 0.227 0.201 DBMET03693 | DBMET03693 | |
| 0.11 | 0.503 | 0.665 | Antiinflammatory | 0.635 0.044 DBMET03696 0.665 0.038 DBMET03693 | DBMET03693 | |
| 0.037 | 0.435 | 0.218 | Platelet antagonist | 0.218 0.089 DBMET03696 0.209 0.095 DBMET03693 | DBMET03696 | |
| 0.041 | 0.44 | 0.315 | Platelet adhesion inhibitor | 0.304 0.033 DBMET03696 0.315 0.029 DBMET03693 | DBMET03693 | |
| 0.024 | 0.494 | 0.167 | Anticoagulant | 0.167 0.068 DBMET03696 0.161 0.071 DBMET03693 | DBMET03696 | |
| 0.007 | 0.492 | 0.064 | Follicle-stimulating hormone antagonist | 0.064 0.003 DBMET03695 | DBMET03695 | |
| 0.016 | 0.54 | 0.053 | Factor IXa inhibitor | 0.053 0.034 DBMET03696 0.051 0.035 DBMET03693 | DBMET03696 | |
| 0.049 | 0.582 | 0.31 | Immunomodulator | 0.305 0.079 DBMET03696 0.31 0.076 DBMET03693 | DBMET03693 | |
| 0.009 | 0.545 | 0.16 | Purinergic P2Y2 antagonist | 0.16 0.003 DBMET03695 | DBMET03695 | |
| 0.013 | 0.555 | 0.243 | Autotaxin inhibitor | 0.243 0.005 DBMET03695 | DBMET03695 | |
| 0.005 | 0.568 | 0.133 | Purinergic P2 antagonist | 0.133 0.013 DBMET03695 | DBMET03695 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |